Monday, Jul 24: 9:30 AM - 10:15 AM
Keynote Lectures
Palais
Room: 210A-F
Nonhuman primates, especially macaque and marmoset monkeys, are excellent models for elucidating highly organized brain function and behavior. However, the ability to manipulate and study these brains at a network level is currently limited due to the lack of genetic neuromodulation tools available. To address this issue, our team has been exploring the use of chemogenetic technology known as Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) in nonhuman primates. DREADDs provide a means to reversibly and remotely control the activity of a neuronal population expressing designer receptors through delivery of their agonist. By combining DREADDs with PET and MR imaging, we have developed a powerful tool for nonhuman primate research that enables the visualization and manipulation of specific brain circuits, and the monitoring of changes in network activity. This technology provides exciting prospects for understanding the link between primate brain circuits and behavior, as well as the development of therapeutic applications.